Antidiabetic Effects of Vigna nakashimae Extract in Humans: A Preliminary Study
Publication: The Journal of Alternative and Complementary Medicine
Volume 24, Issue Number 3
Abstract
Background: Vigna nakashimae (VN) extract has been shown to have antidiabetic and antiobesity effects in various animal studies; however, to our knowledge, no data on such effects exist in humans.
Methods: We performed a randomized placebo-controlled study to investigate the antidiabetic effects of VN extract treatment for 12 weeks in humans. A total of 18 Korean patients with type 2 diabetes were enrolled in this study and were allocated randomly to either the VN extract group (1 g thrice daily) or control group (placebo tablets) for 12 weeks. We investigated blood glucose levels, body weight, lipid profiles, and adverse events after 12 weeks of treatment. Fifteen subjects were included in the final analysis.
Results: There was no difference in age, sex, fasting glucose levels, or lipid profiles between the VN extract and control groups at baseline. However, the baseline glycosylated hemoglobin (HbA1c) levels of the control group were lower than those of the VN extract group. After treatment with VN extract for 12 weeks, the body weight and lipid profile of the VN extract group remained unchanged; however, the HbA1C levels decreased by 0.36% ± 0.33% (p = 0.027). In contrast, the HbA1C levels of the control group did not change after 12 weeks (p = 0.228). During the 12-week treatment with VN extract, no serious adverse events were reported.
Conclusion: Our data indicate that VN extract has implications for glucose lowering in type 2 diabetic patients.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Koo BK, Moon MK. Are we in the same risk of diabetes mellitus? Gender- and age-specific epidemiology of diabetes in 2001 to 2014 in the Korean population. Diabetes Metab J 2016;40:175–181.
2.
Jung JH, Lee JH, Noh JW, et al. Current status of management in type 2 diabetes mellitus at general hospitals in South Korea. Diabetes Metab J 2015;39:307–315.
3.
Lee MS, Lee MS, Lim HJ, et al. Survey of the use of complementary and alternative medicine among Korean diabetes mellitus patients. Pharmacoepidemiol Drug Saf 2004;13:167–171.
4.
Tsuneki H, Ishizuka M, Terasawa M, et al. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 2004;4:18.
5.
Choudhary M, Kochhar A, Sangha J. Hypoglycemic and hypolipidemic effect of Aloe vera L. in non-insulin dependent diabetics. J Food Sci Technol 2014;51:90–96.
6.
Khan A, Khattak KN, Safdar M, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215–3218.
7.
Itoh T, Kobayashi M, Horio F, et al. Hypoglycemic effect of hot-water extract of adzuki (Vigna angularis) in spontaneously diabetic KK-A(y) mice. Nutrition 2009;25:134–141.
8.
Solanki YB, Jain SM. Antihyperlipidemic activity of Clitoria ternatea and Vigna mungo in rats. Pharm Biol 2010;48:915–923.
9.
Itoh T, Furuichi Y. Lowering serum cholesterol level by feeding a 40% ethanol-eluted fraction from HP-20 resin treated with hot water extract of adzuki beans (Vigna angularis) to rats fed a high-fat cholesterol diet. Nutrition 2009;25:318–321.
10.
Mambully C, GopinathanCherukuri R, BabuSukumar R, et al. Nutritional potential of Vigna minima (Roxb.) Ohwi and Ohashi: I. Seed protein content and amino acid composition. Plant Foods Hum Nutr 1987;36:345–355.
11.
Yeo JY, Ha TJ, Nam JS, et al. Antidiabetic effects of Vigna nakashimae extract in db/db mice. Biosci Biotechnol Biochem 2011;75:2223–2228.
12.
Son Y, Nam JS, Jang MK, et al. Antiobesity activity of Vigna nakashimae extract in high-fat diet-induced obesity. Biosci Biotechnol Biochem 2013;77:332–338.
13.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
14.
Tang D, Dong Y, Ren H, et al. A review of phytochemistry, metabolite changes, and medicinal uses of the common food mung bean and its sprouts (Vigna radiata). Chem Cent J 2014;8:4.
15.
Itoh T, Kita N, Kurokawa Y, et al. Suppressive effect of a hot water extract of adzuki beans (Vigna angularis) on hyperglycemia after sucrose loading in mice and diabetic rats. Biosci Biotechnol Biochem 2004;68:2421–2426.
16.
Sreerama YN, Takahashi Y, Yamaki K. Phenolic antioxidants in some Vigna species of legumes and their distinct inhibitory effects on α-glucosidase and pancreatic lipase activities. J Food Sci 2012;77:927–933.
17.
Yao Y, Yang X, Tian J, et al. Antioxidant and antidiabetic activities of black mung bean (Vigna radiata L.). J Agric Food Chem 2013;61:8104–8109.
18.
Strojek K, Raz I, Jermendy G, et al. Factors associated with cardiovascular events in patients with type 2 diabetes and acute myocardial infarction. J Clin Endocrinol Metab 2016;101:243–253.
19.
Amiot MJ, Riva C, Vinet A. Effects of dietary polyphenols on metabolic syndrome features in humans: A systematic review. Obes Rev 2016;17:573–586.
20.
Son Y, Jang MK, Jung MH. Vigna nakashimae extract prevents hepatic steatosis in obese mice fed high-fat diets. J Med Food 2014;17:1322–1331.
21.
Azuma K, Toyofuku Y, Iesaki T, et al. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 2006;345:688–693.
22.
Jeon BT, Heo RW, Shin HJ, et al. Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice. Biosci Biotechnol Biochem 2014;78:482–489.
23.
Medagama AB, Bandara R. The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: Is continued use safe and effective? Nutr J 2014;13:102.
24.
Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine 1995;2:137–189.
Information & Authors
Information
Published In
The Journal of Alternative and Complementary Medicine
Volume 24 • Issue Number 3 • March 2018
Pages: 249 - 253
PubMed: 28976210
Copyright
Copyright 2018, Mary Ann Liebert, Inc.
History
Published in print: March 2018
Published online: 1 March 2018
Published ahead of print: 4 October 2017
Topics
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.